TNFSF11 and neoplasm: In the presence of an osteolytic bone metastasis, the tumor cells secrete osteoclast-activating factors including PTHrP, RANKL, interleukins, and TNFα, and reduce the activity of OPG which further activate the RANK-RANKL pathway.